Paul Conarty, MD
Colon & Rectal Surgery · Fort Wayne, INNPI 1811989908
Payments from drug & device makers
What this record shows
This record is dominated by education: $3,000 of the $3,594 with a category attached, or 83.5%. Intuitive Surgical accounts for 86.3% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2021 at $3,100 and has fallen 97.0% since, to $92 in 2025.
Across 29 payments — averaging $123.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$3K
- Johnson & Johnson$84
- Braintree Laboratories, Inc.$76
- Davol Inc.$46
- Cook Medical LLC$39
- TELA Bio, Inc.$39
- plus $211 from 9 others
What the payments were for
- Food & beverage$59417%
- Education$3,00083%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 2 | $3,100 |
| Johnson & Johnson(2 entities) | 5 | $84 |
| Braintree Laboratories, Inc. | 3 | $76 |
| Davol Inc. | 2 | $46 |
| Cook Medical LLC | 3 | $39 |
| TELA Bio, Inc. | 2 | $39 |
| Shire North American Group Inc | 3 | $36 |
| Merck | 2 | $34 |
| Baxter Healthcare | 1 | $31 |
| Shionogi Inc | 1 | $29 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25 |
| Covidien LP | 1 | $15 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $14 |
| Acera Surgical, Inc. | 1 | $14 |
| Hollister Incorporated | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$3,000
How this compares
$3,594 in reported general payments places this provider in the 60th percentile of 54 colon & rectal surgery providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Mesalamine | 11 | $4,458 |
| Dicyclomine Hcl | 11 | $581 |
| Mupirocin | 69 | $560 |
| Chlorhexidine Gluconate | 83 | $460 |
| Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine | 11 | $279 |
| Hydrocortisone | 33 | $125 |
| Neomycin Sulfate | 22 | $123 |
| Metronidazole | 23 | $30 |
| Metoclopramide Hcl | 23 | $16 |
Paid to pharmacies, not to this prescriber.
Other colon & rectal surgery in Fort Wayne
- Joshua WalletFort Wayne$14K
- Kelly KlinkerFort Wayne$12K
- Ga-Ram HanFort Wayne$9K
- Mithun ShenoiFort Wayne$5K
- Hisham ElhassanFort Wayne$5K
- James EdlundFort Wayne$4K
- Virendra ParikhFort Wayne$3K
- Glenn GoldsteinFort Wayne$3K
- James ConnerFort Wayne$1K
- Nadine FloydFort Wayne$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.